{"disease":{"id":"advanced-or-metastatic-liposarcoma-or-leiomyosarcoma","name":"advanced or metastatic liposarcoma or leiomyosarcoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03009201","title":"Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"OHSU Knight Cancer Institute","has_results":false},{"nct_id":"NCT01692678","title":"A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"Xian-Janssen Pharmaceutical Ltd.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}